{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T05:04:06Z","timestamp":1747890246798,"version":"3.41.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Korea government (MSIP)","award":["2008-0062279"],"award-info":[{"award-number":["2008-0062279"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Peptides"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.peptides.2015.03.022","type":"journal-article","created":{"date-parts":[[2015,4,6]],"date-time":"2015-04-06T08:51:59Z","timestamp":1428310319000},"page":"1-8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Attenuation of renovascular hypertension by cyclooxygenase-2 inhibitor partly through ANP release"],"prefix":"10.1016","volume":"69","author":[{"given":"Byung Mun","family":"Park","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung Ah","family":"Cha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suhn Hee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.peptides.2015.03.022_bib0210","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1530\/eje.0.1330255","article-title":"Myocardial production of prostaglandins: its role in atrial natriuretic peptide release","volume":"133","author":"Azizi","year":"1995","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.peptides.2015.03.022_bib0215","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1016\/j.peptides.2009.06.011","article-title":"Regulation of ANP secretion from isolated atria by prostaglandins and cyclooxygenase-2","volume":"30","author":"Bai","year":"2009","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2015.03.022_bib0220","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1139\/Y10-112","article-title":"Effect of celecoxib on the antihypertensive effect of losartan in a rat model of renovascular hypertension","volume":"89","author":"Boshra","year":"2011","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.peptides.2015.03.022_bib0225","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1113\/jphysiol.1993.sp019790","article-title":"Extracellular fluid translocation in perfused rabbit atria: implication in control of atrial natriuretic peptide secretion","volume":"468","author":"Cho","year":"1993","journal-title":"J Physiol"},{"key":"10.1016\/j.peptides.2015.03.022_bib0230","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1113\/eph8702302","article-title":"Mechanical control of extracellular space in rabbit atria: an intimate modulator of the translocation of extracellular fluid and released atrial natriuretic peptide","volume":"87","author":"Cho","year":"2002","journal-title":"Exp Physiol"},{"key":"10.1016\/j.peptides.2015.03.022_bib0235","first-page":"R39","article-title":"Atrial pressure, distension, and pacing frequency in ANP secretion in isolated perfused rabbit atria","volume":"260","author":"Cho","year":"1991","journal-title":"Am J Physiol"},{"key":"10.1016\/j.peptides.2015.03.022_bib0240","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0167-0115(88)90110-3","article-title":"Characteristics of distension-induced release of immunoreactive atrial natriuretic peptide in isolated perfused rabbit atria","volume":"22","author":"Cho","year":"1988","journal-title":"Regul Pept"},{"key":"10.1016\/j.peptides.2015.03.022_bib0245","doi-asserted-by":"crossref","first-page":"601","DOI":"10.3109\/10641963.2013.776567","article-title":"Etoricoxib attenuates effect of antihypertensives in a rodent model of DOCA-salt induced hypertension","volume":"35","author":"Chugh","year":"2013","journal-title":"Clin Exp Hypertens"},{"key":"10.1016\/j.peptides.2015.03.022_bib0250","doi-asserted-by":"crossref","first-page":"H117","DOI":"10.1152\/ajpheart.2000.278.1.H117","article-title":"Role of cell contractions in cAMP-induced cardiomyocyte atrial natriuretic peptide release","volume":"278","author":"Church","year":"2000","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"Pt 1","key":"10.1016\/j.peptides.2015.03.022_bib0255","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1042\/bj3030217","article-title":"Role of prostaglandin-mediated cyclic AMP formation in protein kinase C-dependent secretion of atrial natriuretic peptide in rat cardiomyocytes","volume":"303","author":"Church","year":"1994","journal-title":"Biochem J"},{"key":"10.1016\/j.peptides.2015.03.022_bib0260","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/(SICI)1097-010X(19960601\/15)275:2\/3<226::AID-JEZ14>3.0.CO;2-H","article-title":"Distribution and molecular forms of urotensin II and its role in cardiovascular regulation in vertebrates","volume":"275","author":"Conlon","year":"1996","journal-title":"J Exp Zoo"},{"key":"10.1016\/j.peptides.2015.03.022_bib0265","doi-asserted-by":"crossref","first-page":"43","DOI":"10.31053\/1853.0605.v60.n1.33763","article-title":"Natriuretic peptides as markers of cardiovascular disease. Their use in diagnosis, prognosis and therapy","volume":"60","author":"de Bold","year":"2003","journal-title":"Rev Fac Cien Med Univ Nac Cordoba"},{"key":"10.1016\/j.peptides.2015.03.022_bib0270","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1139\/y11-019","article-title":"Thirty years of research on atrial natriuretic factor: historical background and emerging concepts","volume":"89","author":"de Bold","year":"2011","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.peptides.2015.03.022_bib0275","doi-asserted-by":"crossref","first-page":"371","DOI":"10.2310\/6650.2005.53710","article-title":"Determinants of natriuretic peptide production by the heart: basic and clinical implications","volume":"53","author":"de Bold","year":"2005","journal-title":"J Investig Med"},{"key":"10.1016\/j.peptides.2015.03.022_bib0280","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.cardiores.2005.06.008","article-title":"Mechanisms of atrial natriuretic peptide secretion from the atrium","volume":"68","author":"Dietz","year":"2005","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.peptides.2015.03.022_bib0285","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.peptides.2013.06.008","article-title":"Angiotensin AT2 receptor agonist stimulates high stretch induced-ANP secretion via PI3K\/NO\/sGC\/PKG\/pathway","volume":"47","author":"Gao","year":"2013","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2015.03.022_bib0290","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1172\/JCI114714","article-title":"Prostaglandins regulate the synthesis and secretion of the atrial natriuretic peptide","volume":"86","author":"Gardner","year":"1990","journal-title":"J Clin Invest"},{"key":"10.1016\/j.peptides.2015.03.022_bib0295","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1161\/01.HYP.0000107779.92645.89","article-title":"Attenuation of lysophosphatidylcholine-induced suppression of ANP release from hypertrophied atria","volume":"43","author":"Han","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.peptides.2015.03.022_bib0300","first-page":"742","article-title":"Cardiac hypertrophy induced by prostaglandin F(2alpha) may be mediated by calcineurin signal transduction pathway in rats","volume":"57","author":"Jiang","year":"2005","journal-title":"Sheng Li Xue Bao"},{"key":"10.1016\/j.peptides.2015.03.022_bib0305","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1440-1681.2007.04534.x","article-title":"Cyclo-oxygenase-2 inhibition attenuates the progression of nephropathy in uninephrectomized diabetic rats","volume":"34","author":"Komers","year":"2007","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.peptides.2015.03.022_bib0310","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1139\/y91-224","article-title":"Arachidonic acid metabolites regulate the secretion of atrial natriuretic peptide in cultured rat atrial cardiocytes","volume":"69","author":"Kovacic-Milivojevic","year":"1991","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.peptides.2015.03.022_bib0315","first-page":"H2197","article-title":"Prostaglandin F2 alpha induces cardiac myocyte hypertrophy in vitro and cardiac growth in vivo","volume":"271","author":"Lai","year":"1996","journal-title":"Am J Physiol"},{"key":"10.1016\/j.peptides.2015.03.022_bib0320","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1177\/153537020422900108","article-title":"Different responses of atrial natriuretic peptide secretion and its receptor density to salt intake in rats","volume":"229","author":"Lee","year":"2004","journal-title":"Exp Biol Med"},{"key":"10.1016\/j.peptides.2015.03.022_bib0325","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0090-6980(02)00029-1","article-title":"Distinct functions of COX-1 and COX-2","volume":"68\u201369","author":"Morita","year":"2002","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"10.1016\/j.peptides.2015.03.022_bib0330","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1291\/hypres.25.927","article-title":"Cyclooxygenase-2 inhibitors attenuate increased blood pressure in renovascular hypertensive models, but not in deoxycorticosterone-salt hypertension","volume":"25","author":"Okumura","year":"2002","journal-title":"Hypertens Res"},{"key":"10.1016\/j.peptides.2015.03.022_bib0335","doi-asserted-by":"crossref","first-page":"F612","DOI":"10.1152\/ajprenal.00032.2006","article-title":"Cyclooxygenase-2 inhibition normalizes arterial blood pressure in CYP1A1-REN2 transgenic rats with inducible ANG II-dependent malignant hypertension","volume":"291","author":"Opay","year":"2006","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.peptides.2015.03.022_bib0340","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1054\/plef.2001.0291","article-title":"Angiotensin II stimulates PGF(2 alpha)release in cultured neonatal rat ventricular myocytes via L-type calcium channels","volume":"65","author":"Oriji","year":"2001","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1016\/j.peptides.2015.03.022_bib0345","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.peptides.2013.01.018","article-title":"Angiotensin III stimulates high stretch-induced ANP secretion via angiotensin type 2 receptor","volume":"42","author":"Park","year":"2013","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2015.03.022_bib0350","doi-asserted-by":"crossref","first-page":"F534","DOI":"10.1152\/ajprenal.00535.2013","article-title":"COX2 inhibition during nephrogenic period induces ANG II hypertension and sex-dependent changes in renal function during aging","volume":"306","author":"Reverte","year":"2014","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.peptides.2015.03.022_bib0355","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/00004872-200401000-00029","article-title":"Chronic cyclooxygenase-2 inhibition does not alter blood pressure and kidney function in renovascular hypertensive rats","volume":"22","author":"Richter","year":"2004","journal-title":"J Hypertens"},{"key":"10.1016\/j.peptides.2015.03.022_bib0360","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/0024-3205(93)90170-8","article-title":"Single injection of pentobarbital induces long-lasting effects on ANP synthesis and gene expression in the rat atria","volume":"52","author":"Seul","year":"1993","journal-title":"Life Sci"},{"key":"10.1016\/j.peptides.2015.03.022_bib0365","doi-asserted-by":"crossref","first-page":"H1365","DOI":"10.1152\/ajpheart.00608.2009","article-title":"Angiotensin-(1-7) stimulates high atrial pacing-induced ANP secretion via Mas\/PI3-kinase\/Akt axis and Na+\/H+ exchanger","volume":"298","author":"Shah","year":"2010","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.peptides.2015.03.022_bib0370","first-page":"R237","article-title":"Mechanism of anoxia-induced atrial natriuretic peptide release in the isolated rat atria","volume":"271","author":"Skvorak","year":"1996","journal-title":"Am J Physiol"},{"key":"10.1016\/j.peptides.2015.03.022_bib0375","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s11010-008-9806-5","article-title":"Angiotensin II bi-directionally regulates cyclooxygenase-2 expression in intestinal epithelial cells","volume":"315","author":"Tani","year":"2008","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.peptides.2015.03.022_bib0380","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/00004872-200303000-00027","article-title":"Inhibition of COX-2 prevents hypertension and proteinuria associated with a decrease of 8-iso-PGF2alpha formation in l-NAME-treated rats","volume":"21","author":"Tomida","year":"2003","journal-title":"J Hypertens"},{"key":"10.1016\/j.peptides.2015.03.022_bib0385","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/BF00223432","article-title":"Significance of myocardial eicosanoid production","volume":"88","author":"van Bilsen","year":"1989","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.peptides.2015.03.022_bib0390","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1161\/01.HYP.34.1.96","article-title":"Cyclooxygenase-2 inhibition decreases renin content and lowers blood pressure in a model of renovascular hypertension","volume":"34","author":"Wang","year":"1999","journal-title":"Hypertension"},{"key":"10.1016\/j.peptides.2015.03.022_bib0395","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1038\/ajh.2011.137","article-title":"Cyclo-oxygenase-2 knockout genotype in mice is associated with blunted angiotensin II-induced oxidative stress and hypertension","volume":"24","author":"Wu","year":"2011","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.peptides.2015.03.022_bib0400","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1161\/01.HYP.0000164572.92049.29","article-title":"Cyclooxygenase-2 inhibitors attenuate angiotensin II-induced oxidative stress, hypertension, and cardiac hypertrophy in rats","volume":"45","author":"Wu","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.peptides.2015.03.022_bib0405","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.peptides.2008.02.011","article-title":"Different response of ANP secretion to adrenoceptor stimulation in renal hypertensive rat atria","volume":"29","author":"Yuan","year":"2008","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2015.03.022_bib0410","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1038\/sj.bjp.0706800","article-title":"The role of urotensin II in cardiovascular and renal physiology and diseases","volume":"148","author":"Zhu","year":"2006","journal-title":"Br J Pharmacol"}],"container-title":["Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978115000893?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978115000893?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T22:57:40Z","timestamp":1747868260000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196978115000893"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":41,"alternative-id":["S0196978115000893"],"URL":"https:\/\/doi.org\/10.1016\/j.peptides.2015.03.022","relation":{},"ISSN":["0196-9781"],"issn-type":[{"type":"print","value":"0196-9781"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Attenuation of renovascular hypertension by cyclooxygenase-2 inhibitor partly through ANP release","name":"articletitle","label":"Article Title"},{"value":"Peptides","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.peptides.2015.03.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}